EpiFaith®, The Innovative Epidural Safeguard, Now Arrives in APAC Hos...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 18, 2024

Canada brings the world together in pursuit of an ambitious global deal to end plastic pollution • Sundial Media Group Extends Its Reach, Further Diversifying the Media Landscape • Franklin Covey Announces New Common Share Purchase Plan • Yom HaAliyah: The International Fellowship of Christians and Jews Celebrates Helping Thousands of Jews Make Aliyah in 2023 • Dr. Cathleen Brown Named Medical Director of Winona, Pioneering Menopause Telehealth Company • Dr. Laurie Leshin, Director of JPL, to Receive THE MUSES of the California Science Center Foundation 2024 Woman of the Year Awar • Wheels in Motion: Nationwide Ride of a Life Time Cycling Event Set for April 27 to Support Children's Health • Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disor • Targeting A Solution Panel Aims to Find Solutions for the Veteran Suicide Crisis with National Thought Leaders Tulsi Gabbard, Ti • Innovafeed Expands to U.S.; French Agtech Firm Opens Insect Innovation Center in Decatur, Ill. • WK Kellogg Co and Meijer Donate $50,000 to Battle Creek Public Schools Mission Tiger • The UAE’s Largest Higher Education Institution, Higher Colleges of Technology, Selects YuJa Video Platform to Serve More t • Angels Helpers NYC Announces 2024 Charity Gala “Big City, Big Hearts: New Yorkers Helping New Yorkers” • RepTrak Announces 2024 Global RepTrak® 100 Report • Semrush Holdings, Inc. Announces Investor Conference Call to Review First Quarter 2024 Financial Results • First Annual U.S.-Ukraine Veterans' Charity Golf Tournament Announced with General Retired David Petraeus as Guest of Honor • CF Industries Holdings, Inc. Declares Quarterly Dividend and Confirms Dates for First Quarter 2024 Results and Conference Call • Nationally Syndicated “The Bert Show” Hosts Candid Interview with Usher, Who Credits Top Morning-Drive Radio Intervi • SuperWomen Of FMS Leadership Award Nominations Now Open • Bright Horizons Family Solutions Announces Date of First Quarter 2024 Earnings Release and Conference Call

EpiFaith®, The Innovative Epidural Safeguard, Now Arrives in APAC Hospitals

TAIPEI, Taiwan , September 21 /Businesswire/ - Flat Medical Co., Ltd., a MedTech company providing clinical safety solutions, has announced that it has launched its flagship product, EpiFaith®, in the Asia Pacific market.

Following its U.S. and European launch announcement in 2019, the company has been devoted to supplying EpiFaith®, the visualized safety solution for epidural locating, to Western hospitals. At the same time, it has kept working on getting regulatory approval in its hometown market, the Asia Pacific region.

“Epidural is one of the most common procedures we do in our daily practice; most Asian anesthesiologists are good at performing it; colleagues here believe that they can do it easily with the current technique,” said Dr. Wei-Zen Sun, a professor in the Department of Anesthesiology at National Taiwan University Hospital and a medical consultant on Flat Medical’s advisory board. “But the truth is it's not, PDPH and CNS injury in epidural is still a big problem, and, unfortunately, some colleagues chose to neglect the risk. We are happy that the product has finally been approved and launched here to eliminate the accidental dural puncture.”

During the annual meeting of TSA (Taiwanese Society of Anesthesiologists), which took place on September 19 and 20, the company announced its formal launch of EpiFaith® in the Asia Pacific market. “Seriously, I think this product is incredible,” said Dr. Chien-Kun Ting, a professor in the Department of Anesthesiology at Taipei Veteran General Hospital. “We just finished a trial of EpiFaith® for thoracic epidural; it’s impressive that the product can indicate the arrival of the space precisely, even on those tough cases.”

The company got its first regulatory approval in Asia in the second quarter of 2020, from the Taiwanese FDA. It is also working with selected local partners in Australia, Japan, South Korea, India, and Vietnam to have EpiFaith® approved and launched in local markets.

About Flat Medical Co., Ltd.

Flat Medical is a MedTech company focusing on safety solutions for clinical procedures. Supported by key opinion leaders and venture capitalists in the United States, Europe, and Asia, the company is commercializing and developing various applications for its innovative EpiFaith® tech.